Status:
COMPLETED
Prediction Model for Postoperative AKI in Patients Undergoing Lung Transplantation Using Machine Learning
Lead Sponsor:
Pusan National University Yangsan Hospital
Conditions:
Lung Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Since 1963, lung transplantation progress has surged due to immunosuppressive agent advancements. In 2004, 1,815 global lung transplantations were reported. Elderly recipients face impaired lung funct...
Detailed Description
Since the first report of lung transplantation in humans in 1963, there has been rapid progress in both the quantity and quality of lung transplantation, driven by the significant advancements in immu...
Eligibility Criteria
Inclusion
- Adult patients 18 years of age or older who underwent lung transplantation for end-stage lung disease
Exclusion
- None.
Key Trial Info
Start Date :
January 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT06218745
Start Date
January 22 2024
End Date
June 30 2025
Last Update
August 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan National University Yangsan Hospital
Yangsan, South Korea